SALINE NASAL SPRAY

SALINE NASAL SPRAY was reported 4370 times

SALINE NASAL SPRAY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOCARDIAL REPERFUSION INJURY 6 0.1579
1 MYOTONIC DYSTROPHY 5 0.0641
2 GASTROINTESTINAL STOMA OUTPUT DECREASED 5 0.0355
3 NAIL BED INFLAMMATION 8 0.0251
4 TETANY 45 0.0247
5 RAPID CORRECTION OF HYPONATRAEMIA 6 0.0239
6 GASTROINTESTINAL STOMA OUTPUT INCREASED 9 0.0192
7 MATERNAL EXPOSURE DURING DELIVERY 18 0.0182
8 BRACHIAL PLEXOPATHY 4 0.0181
9 PNEUMONITIS ASPIRATION 5 0.0146
10 NASAL MUCOSAL DISORDER 8 0.0137
11 GASTRIC MUCOSA ERYTHEMA 4 0.0121
12 RADIOISOTOPE SCAN ABNORMAL 8 0.0113
13 CAUDA EQUINA SYNDROME 8 0.0104
14 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 11 0.0104
15 STOMA COMPLICATION 10 0.0098
16 STREPTOCOCCAL SEPSIS 10 0.0084
17 OSMOTIC DEMYELINATION SYNDROME 5 0.0068
18 VASCULAR DEVICE INFECTION 30 0.0066
19 PSEUDOMONAL SEPSIS 11 0.0063
20 NEPHROGENIC DIABETES INSIPIDUS 7 0.0061
21 HYPORESPONSIVE TO STIMULI 7 0.0060
22 FACIAL DISCOMFORT 4 0.0056
23 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 18 0.0054
24 EXCESSIVE GRANULATION TISSUE 4 0.0050
25 EXCESSIVE EYE BLINKING 7 0.0047
26 ELECTRIC SHOCK 4 0.0047
27 ENDOCRINE OPHTHALMOPATHY 4 0.0046
28 CANDIDA SEPSIS 4 0.0045
29 CARBON DIOXIDE DECREASED 5 0.0043
30 CEREBROSPINAL FLUID LEAKAGE 8 0.0043
31 STAPHYLOCOCCUS TEST POSITIVE 9 0.0043
32 PROCALCITONIN INCREASED 5 0.0043
33 COLON NEOPLASM 4 0.0041
34 BLOOD CHLORIDE INCREASED 7 0.0040
35 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 5 0.0040
36 HYPERNATRAEMIA 20 0.0040
37 ADMINISTRATION SITE EXTRAVASATION 4 0.0040
38 KOUNIS SYNDROME 9 0.0040
39 BRONCHIAL SECRETION RETENTION 5 0.0039
40 VENTRICULAR ARRHYTHMIA 14 0.0038
41 GASTROINTESTINAL STOMA COMPLICATION 6 0.0038
42 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
43 INCORRECT DRUG ADMINISTRATION RATE 16 0.0038
44 ANION GAP INCREASED 5 0.0037
45 GALLBLADDER ENLARGEMENT 4 0.0037
46 AORTIC DILATATION 4 0.0036
47 AUDITORY DISORDER 5 0.0035
48 INFUSION SITE DISCHARGE 6 0.0034
49 HYPOSMIA 5 0.0033
50 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
51 SPUTUM INCREASED 7 0.0032
52 JAUNDICE NEONATAL 6 0.0032
53 DRUG CLEARANCE DECREASED 4 0.0031
54 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 8 0.0031
55 BILIRUBIN CONJUGATED INCREASED 7 0.0030
56 ESCHERICHIA BACTERAEMIA 7 0.0030
57 SINUS OPERATION 7 0.0029
58 INFUSION SITE EXTRAVASATION 18 0.0029
59 SPINAL CORD INJURY 5 0.0029
60 DEVICE INFUSION ISSUE 7 0.0028
61 PALLOR 75 0.0028
62 PULMONARY FUNCTION TEST DECREASED 12 0.0027
63 INFUSION SITE HAEMORRHAGE 9 0.0027
64 BLOOD SODIUM INCREASED 7 0.0026
65 BRAIN DEATH 8 0.0026
66 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
67 EPIGASTRIC DISCOMFORT 10 0.0026
68 HYPERAEMIA 5 0.0025
69 OBSTRUCTION 10 0.0025
70 CAPILLARY LEAK SYNDROME 5 0.0024
71 CATHETER SITE HAEMORRHAGE 6 0.0024
72 PROTEIN TOTAL DECREASED 9 0.0024
73 RHINOVIRUS INFECTION 9 0.0023
74 ACTINIC KERATOSIS 6 0.0023
75 MULTIPLE ALLERGIES 18 0.0023
76 RESPIRATORY ACIDOSIS 9 0.0023
77 AORTIC VALVE STENOSIS 4 0.0022
78 INFUSION SITE PRURITUS 7 0.0022
79 BILE DUCT STONE 7 0.0022
80 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
81 CYSTIC FIBROSIS 12 0.0022
82 PARAESTHESIA ORAL 31 0.0021
83 VARICOSE VEIN 11 0.0021
84 CONTRAST MEDIA REACTION 5 0.0021
85 PULSE ABNORMAL 5 0.0021
86 BREATH ODOUR 5 0.0020
87 HYPERVOLAEMIA 10 0.0020
88 ENDOPHTHALMITIS 12 0.0020
89 CRANIOCEREBRAL INJURY 6 0.0020
90 BUNDLE BRANCH BLOCK RIGHT 9 0.0020
91 CHANGE OF BOWEL HABIT 4 0.0019
92 METASTASES TO LYMPH NODES 13 0.0019
93 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
94 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
95 INFUSION SITE SWELLING 12 0.0019
96 PNEUMONIA VIRAL 6 0.0019
97 MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0019
98 NORMAL NEWBORN 10 0.0018
99 HEPARIN-INDUCED THROMBOCYTOPENIA 9 0.0018
100 DEAFNESS NEUROSENSORY 6 0.0018
101 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 6 0.0018
102 OLIGOHYDRAMNIOS 6 0.0018
103 ADENOCARCINOMA 4 0.0018
104 HYPERCALCAEMIA 22 0.0018
105 ACUTE RESPIRATORY FAILURE 34 0.0018
106 FORCED EXPIRATORY VOLUME DECREASED 5 0.0018
107 SKIN NECROSIS 9 0.0017
108 HYPERREFLEXIA 6 0.0017
109 PULMONARY PAIN 5 0.0017
110 HYPOVOLAEMIA 10 0.0017
111 DEPRESSIVE SYMPTOM 6 0.0017
112 HYPOXIA 59 0.0017
113 DIABETES INSIPIDUS 4 0.0017
114 HYPERCAPNIA 5 0.0017
115 CANDIDA INFECTION 28 0.0017
116 CYTOKINE RELEASE SYNDROME 33 0.0016
117 BLOOD PHOSPHORUS DECREASED 6 0.0016
118 FOOD INTOLERANCE 6 0.0016
119 DYSCHEZIA 5 0.0016
120 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
121 MASTICATION DISORDER 5 0.0016
122 BLOOD MAGNESIUM DECREASED 14 0.0016
123 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
124 OLIGURIA 10 0.0016
125 INFREQUENT BOWEL MOVEMENTS 4 0.0016
126 CHRONIC SINUSITIS 6 0.0016
127 NASAL DRYNESS 10 0.0016
128 PARONYCHIA 7 0.0016
129 CANCER PAIN 4 0.0016
130 ATELECTASIS 15 0.0016
131 BLOOD CHLORIDE DECREASED 4 0.0015
132 TACHYPNOEA 21 0.0015
133 COMPARTMENT SYNDROME 4 0.0015
134 CARDIOGENIC SHOCK 22 0.0015
135 HYPERSENSITIVITY VASCULITIS 4 0.0015
136 ARTHRITIS INFECTIVE 7 0.0015
137 APPETITE DISORDER 10 0.0015
138 BRAIN OEDEMA 19 0.0015
139 AREFLEXIA 4 0.0015
140 RESPIRATORY TRACT INFECTION 39 0.0015
141 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
142 UNRESPONSIVE TO STIMULI 38 0.0015
143 PRODUCTIVE COUGH 70 0.0015
144 CLONUS 4 0.0015
145 HYPOAESTHESIA ORAL 22 0.0015
146 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
147 GRANULOMA 5 0.0014
148 ANAL HAEMORRHAGE 4 0.0014
149 DRUG TOLERANCE DECREASED 4 0.0014
150 BRONCHIOLITIS 5 0.0014
151 TORSADE DE POINTES 11 0.0014
152 ERYSIPELAS 7 0.0014
153 FLANK PAIN 13 0.0014
154 LOW BIRTH WEIGHT BABY 11 0.0014
155 URINE OUTPUT DECREASED 12 0.0014
156 PRODUCT PREPARATION ISSUE 9 0.0014
157 ASTHMATIC CRISIS 5 0.0014
158 TUMOUR LYSIS SYNDROME 12 0.0014
159 COLD SWEAT 24 0.0014
160 BLOOD CREATINE INCREASED 6 0.0014
161 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 23 0.0014
162 FEELING HOT 83 0.0014
163 DECUBITUS ULCER 11 0.0013
164 WHEELCHAIR USER 6 0.0013
165 SEASONAL ALLERGY 19 0.0013
166 CYANOSIS 21 0.0013
167 PARANASAL SINUS DISCOMFORT 5 0.0013
168 SINUS DISORDER 26 0.0013
169 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
170 HYPOTONIA 13 0.0013
171 WHEEZING 77 0.0013
172 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
173 NEPHROGENIC ANAEMIA 6 0.0013
174 HYPOALBUMINAEMIA 10 0.0013
175 PSEUDOMONAS INFECTION 11 0.0013
176 ORAL INFECTION 5 0.0013
177 SECRETION DISCHARGE 16 0.0013
178 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
179 BLOOD ALBUMIN DECREASED 10 0.0013
180 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
181 POOR VENOUS ACCESS 13 0.0013
182 BLOOD CALCIUM DECREASED 14 0.0012
183 WEIGHT FLUCTUATION 13 0.0012
184 CHOLECYSTITIS ACUTE 7 0.0012
185 MYOCARDIAL ISCHAEMIA 14 0.0012
186 POLYURIA 10 0.0012
187 OROPHARYNGEAL DISCOMFORT 11 0.0012
188 RALES 7 0.0012
189 PREMATURE DELIVERY 19 0.0012
190 UROSEPSIS 11 0.0012
191 HYPOKALAEMIA 55 0.0012
192 BRONCHIECTASIS 8 0.0012
193 KLEBSIELLA INFECTION 6 0.0012
194 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
195 BOWEL MOVEMENT IRREGULARITY 9 0.0012
196 DRUG TOXICITY 16 0.0012
197 POOR PERIPHERAL CIRCULATION 5 0.0012
198 LEUKOCYTOSIS 21 0.0012
199 JOINT EFFUSION 8 0.0012
200 APNOEA 9 0.0012
201 NO THERAPEUTIC RESPONSE 14 0.0011
202 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
203 EAR PRURITUS 4 0.0011
204 PHYSICAL DISABILITY 5 0.0011
205 SINUS TACHYCARDIA 16 0.0011
206 NEUTROPENIC SEPSIS 8 0.0011
207 THIRST 20 0.0011
208 IMPLANT SITE PAIN 5 0.0011
209 MENINGITIS ASEPTIC 5 0.0011
210 BLOOD BILIRUBIN INCREASED 30 0.0011
211 SINUS CONGESTION 15 0.0011
212 BONE LESION 4 0.0011
213 ABNORMAL FAECES 9 0.0011
214 HYPOTHERMIA 11 0.0011
215 OXYGEN SATURATION DECREASED 61 0.0011
216 VENTRICULAR FIBRILLATION 12 0.0011
217 PNEUMOTHORAX 17 0.0011
218 EAR DISCOMFORT 11 0.0011
219 NEPHROPATHY TOXIC 12 0.0011
220 ACUTE PULMONARY OEDEMA 6 0.0011
221 YELLOW SKIN 5 0.0011
222 METABOLIC ACIDOSIS 34 0.0011
223 PERONEAL NERVE PALSY 6 0.0011
224 RESPIRATORY DISTRESS 29 0.0010
225 COMMUNICATION DISORDER 4 0.0010
226 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
227 CHOLECYSTITIS CHRONIC 7 0.0010
228 INCONTINENCE 11 0.0010
229 ENTEROCOLITIS 6 0.0010
230 BRADYCARDIA 55 0.0010
231 SINUS BRADYCARDIA 10 0.0010
232 HYPONATRAEMIA 58 0.0010
233 VENTRICULAR TACHYCARDIA 17 0.0010
234 EJECTION FRACTION DECREASED 16 0.0010
235 CARDIOPULMONARY FAILURE 4 0.0010
236 HEREDITARY ANGIOEDEMA 11 0.0010
237 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
238 HYPOAESTHESIA 153 0.0010
239 PERIPHERAL COLDNESS 14 0.0010
240 C-REACTIVE PROTEIN INCREASED 37 0.0010
241 RESPIRATORY RATE INCREASED 9 0.0010
242 STAPHYLOCOCCAL SEPSIS 5 0.0010
243 MUCOUS STOOLS 5 0.0010
244 RENAL CYST 8 0.0010
245 PNEUMONIA ASPIRATION 25 0.0010
246 ARTERIOSPASM CORONARY 4 0.0010
247 PAIN IN JAW 28 0.0010
248 FOETAL GROWTH RESTRICTION 6 0.0010
249 DRY THROAT 10 0.0010
250 DYSPNOEA EXERTIONAL 37 0.0010
251 MOTOR DYSFUNCTION 10 0.0010
252 NEUTROPHIL COUNT INCREASED 10 0.0010
253 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
254 EXTRAVASATION 4 0.0010
255 PARAESTHESIA 153 0.0010
256 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
257 HYPERBILIRUBINAEMIA 10 0.0010
258 PREMATURE BABY 29 0.0010
259 FAILURE TO THRIVE 5 0.0010
260 BLOOD SODIUM DECREASED 18 0.0010
261 SPINAL DISORDER 9 0.0009
262 SERUM FERRITIN INCREASED 5 0.0009
263 HYPOPHOSPHATAEMIA 7 0.0009
264 ABSCESS LIMB 4 0.0009
265 CARDIAC ARREST 77 0.0009
266 HAEMOPTYSIS 26 0.0009
267 ANAL ABSCESS 5 0.0009
268 TROPONIN INCREASED 7 0.0009
269 ACIDOSIS 7 0.0009
270 INSURANCE ISSUE 14 0.0009
271 DIVERTICULUM INTESTINAL 4 0.0009
272 ASPIRATION 10 0.0009
273 ORAL CANDIDIASIS 12 0.0009
274 SPINAL OSTEOARTHRITIS 8 0.0009
275 PULMONARY CONGESTION 12 0.0009
276 STAPHYLOCOCCAL INFECTION 30 0.0009
277 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
278 MUSCULOSKELETAL CHEST PAIN 14 0.0009
279 RED BLOOD CELL SEDIMENTATION RATE INCREASED 10 0.0009
280 RESPIRATORY DISORDER 27 0.0009
281 LOWER RESPIRATORY TRACT INFECTION 41 0.0009
282 BLOOD UREA INCREASED 15 0.0009
283 SMALL INTESTINAL OBSTRUCTION 11 0.0009
284 HAEMARTHROSIS 8 0.0009
285 SNEEZING 20 0.0009
286 POSTOPERATIVE WOUND INFECTION 6 0.0009
287 UPPER RESPIRATORY TRACT INFECTION 41 0.0009
288 SLUGGISHNESS 9 0.0009
289 RESPIRATORY TRACT CONGESTION 14 0.0009
290 HYPERTONIA 5 0.0009
291 ANGINA PECTORIS 25 0.0009
292 MIOSIS 7 0.0009
293 EPISTAXIS 65 0.0009
294 EXERCISE TOLERANCE DECREASED 5 0.0009
295 RHINITIS 7 0.0009
296 LYMPHOEDEMA 6 0.0009
297 PETECHIAE 9 0.0009
298 HYPOMAGNESAEMIA 12 0.0009
299 STRESS CARDIOMYOPATHY 5 0.0009
300 HEPATIC ENCEPHALOPATHY 8 0.0009
301 HICCUPS 7 0.0009
302 ARTERIOSCLEROSIS 8 0.0008
303 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
304 SINUSITIS 87 0.0008
305 LYMPHOCYTE COUNT DECREASED 15 0.0008
306 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
307 COAGULOPATHY 14 0.0008
308 PROTHROMBIN TIME PROLONGED 5 0.0008
309 HYPOVOLAEMIC SHOCK 4 0.0008
310 FAECAL INCONTINENCE 4 0.0008
311 DYSGEUSIA 61 0.0008
312 ORAL DISORDER 6 0.0008
313 MOUTH HAEMORRHAGE 6 0.0008
314 MUSCLE SPASMS 150 0.0008
315 ANURIA 7 0.0008
316 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
317 MEDICAL DEVICE COMPLICATION 6 0.0008
318 BREATH SOUNDS ABNORMAL 4 0.0008
319 PYELONEPHRITIS 7 0.0008
320 MUSCLE TIGHTNESS 13 0.0008
321 CHILLS 94 0.0008
322 BRAIN INJURY 8 0.0008
323 ANAPHYLACTIC REACTION 44 0.0008
324 MENTAL STATUS CHANGES 22 0.0008
325 HEAD DISCOMFORT 14 0.0008
326 APHONIA 11 0.0008
327 HYPOTENSION 158 0.0008
328 DYSLIPIDAEMIA 4 0.0008
329 AMMONIA INCREASED 4 0.0008
330 CHEST DISCOMFORT 80 0.0008
331 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
332 INCREASED UPPER AIRWAY SECRETION 4 0.0008
333 MOVEMENT DISORDER 25 0.0008
334 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
335 INFUSION SITE PAIN 10 0.0008
336 INCOHERENT 5 0.0008
337 EAR PAIN 15 0.0008
338 CARDIO-RESPIRATORY ARREST 32 0.0008
339 PNEUMONIA BACTERIAL 7 0.0008
340 HYPERHIDROSIS 98 0.0008
341 BLOOD LACTIC ACID INCREASED 4 0.0008
342 PULMONARY OEDEMA 34 0.0008
343 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
344 NASAL DISCOMFORT 6 0.0008
345 CARDIAC FAILURE ACUTE 5 0.0007
346 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
347 FOOD POISONING 4 0.0007
348 SENSORY LOSS 6 0.0007
349 ABORTION INDUCED 7 0.0007
350 GINGIVITIS 4 0.0007
351 BLOOD POTASSIUM INCREASED 12 0.0007
352 SPUTUM DISCOLOURED 7 0.0007
353 OEDEMA 40 0.0007
354 BLOOD PRESSURE DECREASED 49 0.0007
355 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
356 ANAPHYLACTIC SHOCK 19 0.0007
357 ENCEPHALOPATHY 18 0.0007
358 BLOOD POTASSIUM DECREASED 22 0.0007
359 ECCHYMOSIS 5 0.0007
360 POST PROCEDURAL COMPLICATION 14 0.0007
361 GASTROINTESTINAL PAIN 8 0.0007
362 SEPSIS 81 0.0007
363 INFUSION RELATED REACTION 48 0.0007
364 VIRAL INFECTION 24 0.0007
365 MASS 10 0.0007
366 MALNUTRITION 8 0.0007
367 RIGHT VENTRICULAR FAILURE 5 0.0007
368 OCULAR DISCOMFORT 8 0.0007
369 HEPATOMEGALY 7 0.0007
370 LUNG INFECTION 11 0.0007
371 PULMONARY TOXICITY 5 0.0007
372 BASAL CELL CARCINOMA 11 0.0007
373 THERMAL BURN 5 0.0007
374 BLOOD CREATININE INCREASED 46 0.0007
375 GENERALISED ERYTHEMA 4 0.0007
376 SCAB 8 0.0007
377 BRONCHOSPASM 10 0.0007
378 LIMB INJURY 19 0.0007
379 FLUSHING 71 0.0007
380 SKIN HYPERPIGMENTATION 6 0.0007
381 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
382 ARRHYTHMIA 33 0.0007
383 COUGH 195 0.0007
384 HYPERVENTILATION 4 0.0007
385 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
386 ELECTROLYTE IMBALANCE 8 0.0007
387 EYELID OEDEMA 8 0.0007
388 GASTROENTERITIS 10 0.0007
389 RESTLESSNESS 25 0.0007
390 NASAL CONGESTION 40 0.0007
391 BRADYKINESIA 4 0.0007
392 COVID-19 PNEUMONIA 8 0.0007
393 DEHYDRATION 90 0.0007
394 VENTRICULAR EXTRASYSTOLES 7 0.0007
395 PLEURAL EFFUSION 41 0.0007
396 ASTHMA 76 0.0007
397 PULMONARY HYPERTENSION 14 0.0007
398 TENDERNESS 7 0.0007
399 IMMUNODEFICIENCY 10 0.0007
400 MACULAR DEGENERATION 8 0.0007
401 ALANINE AMINOTRANSFERASE INCREASED 41 0.0007
402 ANAL INCONTINENCE 6 0.0007
403 SEPTIC SHOCK 29 0.0007
404 HAEMORRHOIDS 13 0.0007
405 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
406 GASTROENTERITIS VIRAL 12 0.0007
407 DYSKINESIA 27 0.0007
408 TACHYCARDIA 59 0.0007
409 GANGRENE 4 0.0007
410 FEBRILE NEUTROPENIA 44 0.0007
411 JOINT DISLOCATION 7 0.0007
412 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
413 INGUINAL HERNIA 4 0.0007
414 HAEMODYNAMIC INSTABILITY 5 0.0007
415 DYSPNOEA 370 0.0007
416 RESPIRATORY DEPRESSION 8 0.0007
417 FACE OEDEMA 11 0.0007
418 PROCEDURAL COMPLICATION 5 0.0007
419 LIVER FUNCTION TEST INCREASED 14 0.0007
420 MUSCLE SPASTICITY 8 0.0007
421 INFECTION 94 0.0006
422 THYROID DISORDER 10 0.0006
423 FEELING COLD 18 0.0006
424 ASCITES 19 0.0006
425 THROAT IRRITATION 29 0.0006
426 CIRCULATORY COLLAPSE 11 0.0006
427 PNEUMONIA 209 0.0006
428 SCAR 11 0.0006
429 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
430 SKIN REACTION 9 0.0006
431 EAR INFECTION 17 0.0006
432 HEPATIC CIRRHOSIS 12 0.0006
433 MULTI-ORGAN FAILURE 11 0.0006
434 FLUID RETENTION 32 0.0006
435 GINGIVAL PAIN 5 0.0006
436 ACUTE KIDNEY INJURY 96 0.0006
437 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
438 SEROTONIN SYNDROME 12 0.0006
439 FISTULA 7 0.0006
440 HYPERCHOLESTEROLAEMIA 6 0.0006
441 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
442 RHINORRHOEA 40 0.0006
443 FRUSTRATION TOLERANCE DECREASED 5 0.0006
444 FLATULENCE 35 0.0006
445 RESPIRATORY FAILURE 45 0.0006
446 HERPES SIMPLEX 4 0.0006
447 DERMATITIS CONTACT 7 0.0006
448 PHARYNGEAL SWELLING 6 0.0006
449 RENAL TUBULAR NECROSIS 6 0.0006
450 KIDNEY INFECTION 12 0.0006
451 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
452 DYSARTHRIA 23 0.0006
453 EATING DISORDER 13 0.0006
454 LETHARGY 35 0.0006
455 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
456 HYPERGLYCAEMIA 22 0.0006
457 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
458 MENSTRUAL DISORDER 5 0.0006
459 ACUTE CORONARY SYNDROME 5 0.0006
460 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
461 PYREXIA 207 0.0006
462 INFUSION SITE ERYTHEMA 5 0.0006
463 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
464 FEEDING DISORDER 12 0.0006
465 EYELID PTOSIS 6 0.0006
466 BACTERAEMIA 7 0.0006
467 VITAMIN D DECREASED 5 0.0006
468 CORONARY ARTERY OCCLUSION 8 0.0006
469 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
470 HYPOCALCAEMIA 11 0.0006
471 MUSCLE STRAIN 5 0.0006
472 URINARY INCONTINENCE 17 0.0006
473 MATERNAL EXPOSURE DURING PREGNANCY 51 0.0006
474 NEUROTOXICITY 10 0.0006
475 CARDIOMEGALY 7 0.0006
476 DEVICE OCCLUSION 8 0.0006
477 OSTEOARTHRITIS 24 0.0006
478 LUNG INFILTRATION 5 0.0006
479 GENERALISED OEDEMA 7 0.0006
480 ATRIAL FIBRILLATION 55 0.0006
481 SCIATICA 9 0.0006
482 DYSPHONIA 33 0.0006
483 MUSCLE TWITCHING 13 0.0006
484 CHOKING 11 0.0006
485 JOINT INJURY 12 0.0006
486 AGEUSIA 14 0.0006
487 WRONG DRUG ADMINISTERED 5 0.0006
488 GASTROINTESTINAL INFECTION 5 0.0006
489 PULMONARY EMBOLISM 53 0.0006
490 DECREASED ACTIVITY 6 0.0006
491 FREQUENT BOWEL MOVEMENTS 15 0.0006
492 DISORIENTATION 22 0.0006
493 HAEMATOCRIT DECREASED 11 0.0006
494 ABDOMINAL PAIN 129 0.0006
495 MUSCLE ATROPHY 7 0.0006
496 CARDIOVASCULAR DISORDER 14 0.0006
497 FLUID OVERLOAD 8 0.0005
498 BONE DISORDER 10 0.0005
499 METASTASES TO BONE 9 0.0005
500 EXOSTOSIS 5 0.0005
501 BACK PAIN 127 0.0005
502 MYDRIASIS 7 0.0005
503 CHEST PAIN 101 0.0005
504 URINARY TRACT INFECTION 93 0.0005
505 PRODUCT ADMINISTRATION ERROR 11 0.0005
506 DENTAL CARIES 6 0.0005
507 TASTE DISORDER 11 0.0005
508 RENAL FAILURE ACUTE 23 0.0005
509 IRON DEFICIENCY ANAEMIA 5 0.0005
510 HEART RATE DECREASED 19 0.0005
511 HIATUS HERNIA 7 0.0005
512 NERVE INJURY 6 0.0005
513 PULMONARY MASS 8 0.0005
514 HEPATIC STEATOSIS 10 0.0005
515 APPENDICITIS 5 0.0005
516 VOMITING 251 0.0005
517 CHROMATURIA 12 0.0005
518 STATUS EPILEPTICUS 6 0.0005
519 NIGHT SWEATS 17 0.0005
520 CHOLECYSTECTOMY 6 0.0005
521 HYPERSOMNIA 15 0.0005
522 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
523 LIMB DISCOMFORT 16 0.0005
524 TENDONITIS 8 0.0005
525 CONCUSSION 4 0.0005
526 APHTHOUS ULCER 4 0.0005
527 POST PROCEDURAL HAEMORRHAGE 6 0.0005
528 BRONCHITIS 38 0.0005
529 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
530 SKIN FISSURES 10 0.0005
531 DEPRESSED MOOD 27 0.0005
532 ACUTE MYOCARDIAL INFARCTION 15 0.0005
533 ANAEMIA 97 0.0005
534 HYPOPHAGIA 13 0.0005
535 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
536 FAECES DISCOLOURED 11 0.0005
537 LOSS OF CONSCIOUSNESS 65 0.0005
538 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
539 ATAXIA 6 0.0005
540 WEIGHT DECREASED 141 0.0005
541 PRODUCT PRESCRIBING ISSUE 11 0.0005
542 GALLBLADDER DISORDER 9 0.0005
543 MYOCLONUS 6 0.0005
544 INFLUENZA 56 0.0005
545 ATRIAL FLUTTER 4 0.0005
546 SKIN DISCOLOURATION 23 0.0005
547 SENSORY DISTURBANCE 8 0.0005
548 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
549 RASH MACULO-PAPULAR 11 0.0005
550 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
551 BONE MARROW FAILURE 10 0.0005
552 TOOTH ABSCESS 5 0.0005
553 DYSURIA 18 0.0005
554 PARALYSIS 7 0.0005
555 IMPAIRED QUALITY OF LIFE 7 0.0005
556 ESCHERICHIA INFECTION 4 0.0005
557 INJECTION SITE EXTRAVASATION 6 0.0005
558 NECK PAIN 27 0.0005
559 PRODUCT AVAILABILITY ISSUE 11 0.0005
560 BACTERIAL INFECTION 9 0.0005
561 FOETAL EXPOSURE DURING PREGNANCY 39 0.0005
562 TINNITUS 22 0.0005
563 PNEUMONITIS 13 0.0005
564 HAEMODIALYSIS 4 0.0005
565 OEDEMA PERIPHERAL 58 0.0005
566 SCRATCH 5 0.0005
567 THROMBOCYTOPENIA 53 0.0005
568 RESPIRATORY ARREST 13 0.0005
569 LUNG DISORDER 23 0.0005
570 HAEMORRHAGE 49 0.0005
571 PROCEDURAL PAIN 13 0.0005
572 NASOPHARYNGITIS 86 0.0005
573 BREAST CANCER METASTATIC 5 0.0005
574 WOUND 13 0.0005
575 MUSCULOSKELETAL DISCOMFORT 8 0.0005
576 HEPATIC FAILURE 14 0.0005
577 APHASIA 14 0.0005
578 LACTIC ACIDOSIS 15 0.0005
579 CARDIAC MURMUR 4 0.0005
580 DIPLOPIA 12 0.0005
581 BEDRIDDEN 6 0.0005
582 BLOOD CALCIUM INCREASED 4 0.0005
583 TOOTH INFECTION 6 0.0005
584 LOCALISED INFECTION 11 0.0005
585 DIZZINESS 226 0.0005
586 PRESYNCOPE 11 0.0005
587 NEURALGIA 11 0.0005
588 FUNGAL INFECTION 15 0.0004
589 TRANSAMINASES INCREASED 10 0.0004
590 EYE HAEMORRHAGE 6 0.0004
591 URINARY RETENTION 15 0.0004
592 NAUSEA 355 0.0004
593 DECREASED APPETITE 104 0.0004
594 QUALITY OF LIFE DECREASED 6 0.0004
595 FULL BLOOD COUNT DECREASED 9 0.0004
596 GOUT 8 0.0004
597 SKIN INFECTION 5 0.0004
598 STOMATITIS 27 0.0004
599 PRODUCT USE COMPLAINT 7 0.0004
600 THROAT TIGHTNESS 12 0.0004
601 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
602 RECTAL HAEMORRHAGE 19 0.0004
603 OSTEOMYELITIS 8 0.0004
604 SEIZURE 51 0.0004
605 HYPOTHYROIDISM 14 0.0004
606 CATARACT 26 0.0004
607 PERITONITIS 9 0.0004
608 TREMOR 72 0.0004
609 PERICARDIAL EFFUSION 10 0.0004
610 BLOOD PRESSURE INCREASED 66 0.0004
611 HUNGER 6 0.0004
612 BACK DISORDER 7 0.0004
613 RASH MACULAR 15 0.0004
614 HAEMOGLOBIN DECREASED 44 0.0004
615 HYPERKALAEMIA 15 0.0004
616 EYE PAIN 24 0.0004
617 PHOTOPHOBIA 8 0.0004
618 RETCHING 9 0.0004
619 ANXIETY 120 0.0004
620 BLOOD URINE PRESENT 8 0.0004
621 OROPHARYNGEAL PAIN 39 0.0004
622 MUCOSAL INFLAMMATION 11 0.0004
623 SLEEP APNOEA SYNDROME 8 0.0004
624 MUSCLE RIGIDITY 5 0.0004
625 GASTRITIS 11 0.0004
626 POLYNEUROPATHY 5 0.0004
627 ASTHENIA 157 0.0004
628 ILLNESS 43 0.0004
629 CELLULITIS 21 0.0004
630 LOWER LIMB FRACTURE 8 0.0004
631 SWOLLEN TONGUE 13 0.0004
632 ANOSMIA 6 0.0004
633 HYPERTHYROIDISM 6 0.0004
634 NEPHROLITHIASIS 19 0.0004
635 HERNIA 8 0.0004
636 BURSITIS 5 0.0004
637 ADRENAL INSUFFICIENCY 5 0.0004
638 NOCTURIA 5 0.0004
639 ACCIDENTAL OVERDOSE 15 0.0004
640 DISCOMFORT 25 0.0004
641 VISION BLURRED 56 0.0004
642 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
643 BODY TEMPERATURE DECREASED 4 0.0004
644 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
645 HEPATOTOXICITY 9 0.0004
646 DELIRIUM 14 0.0004
647 PHARYNGITIS 5 0.0004
648 COLON CANCER 6 0.0004
649 OFF LABEL USE 352 0.0004
650 HEPATIC FUNCTION ABNORMAL 15 0.0004
651 TOOTH EXTRACTION 5 0.0004
652 PREGNANCY 8 0.0004
653 PAIN 245 0.0004
654 CARDIAC FAILURE 32 0.0004
655 INTESTINAL OBSTRUCTION 15 0.0004
656 EMPHYSEMA 4 0.0004
657 CHOLELITHIASIS 13 0.0004
658 LYMPHADENOPATHY 14 0.0004
659 RENAL IMPAIRMENT 33 0.0004
660 BODY TEMPERATURE INCREASED 8 0.0004
661 PHARYNGEAL OEDEMA 6 0.0004
662 DYSPHAGIA 37 0.0004
663 DEVICE RELATED INFECTION 6 0.0004
664 PERIPHERAL SWELLING 60 0.0004
665 MIGRAINE 37 0.0004
666 INFLAMMATION 20 0.0004
667 RED BLOOD CELL COUNT DECREASED 11 0.0004
668 DEEP VEIN THROMBOSIS 25 0.0004
669 THERAPY PARTIAL RESPONDER 6 0.0004
670 NERVOUS SYSTEM DISORDER 12 0.0004
671 PLASMA CELL MYELOMA 15 0.0004
672 ERYTHEMA 79 0.0004
673 END STAGE RENAL DISEASE 7 0.0004
674 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
675 ABDOMINAL DISTENSION 40 0.0004
676 BRAIN FOG 6 0.0004
677 SPEECH DISORDER 20 0.0004
678 GENERAL PHYSICAL HEALTH DETERIORATION 44 0.0004
679 LEUKOPENIA 19 0.0004
680 MOUTH ULCERATION 8 0.0004
681 ABDOMINAL PAIN UPPER 78 0.0004
682 CONFUSIONAL STATE 61 0.0004
683 CYSTITIS 12 0.0004
684 DYSSTASIA 11 0.0004
685 ABSCESS 6 0.0004
686 MIDDLE INSOMNIA 7 0.0004
687 BODY HEIGHT DECREASED 4 0.0004
688 HEART RATE INCREASED 37 0.0004
689 HYPERTENSION 79 0.0004
690 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
691 MALAISE 162 0.0004
692 NEUTROPHIL COUNT DECREASED 15 0.0004
693 MENTAL DISORDER 16 0.0004
694 AGITATION 27 0.0004
695 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
696 GINGIVAL BLEEDING 5 0.0004
697 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
698 URTICARIA 61 0.0004
699 OSTEONECROSIS OF JAW 9 0.0004
700 NERVOUSNESS 19 0.0004
701 GLAUCOMA 7 0.0004
702 SWELLING 34 0.0004
703 HYPERSENSITIVITY 67 0.0004
704 TOOTH DISORDER 8 0.0004
705 POLLAKIURIA 15 0.0004
706 HYPERTENSIVE CRISIS 4 0.0004
707 ORAL HERPES 7 0.0004
708 PANCYTOPENIA 20 0.0004
709 EYE PRURITUS 12 0.0004
710 INTESTINAL PERFORATION 4 0.0004
711 BLISTER 20 0.0004
712 THERAPY NON-RESPONDER 16 0.0004
713 PANCREATITIS ACUTE 8 0.0004
714 DYSPEPSIA 35 0.0004
715 EYE INFECTION 4 0.0004
716 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
717 MUSCULAR WEAKNESS 40 0.0004
718 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
719 HAEMATURIA 12 0.0004
720 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
721 HYPOACUSIS 15 0.0003
722 HEAD INJURY 11 0.0003
723 HAEMATOMA 9 0.0003
724 DISEASE PROGRESSION 41 0.0003
725 FALL 115 0.0003
726 VERTIGO 21 0.0003
727 DEAFNESS 9 0.0003
728 SEDATION 9 0.0003
729 NEEDLE ISSUE 10 0.0003
730 HEADACHE 215 0.0003
731 PALPITATIONS 40 0.0003
732 PRODUCT PREPARATION ERROR 7 0.0003
733 ABDOMINAL DISCOMFORT 57 0.0003
734 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
735 DIARRHOEA 219 0.0003
736 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
737 HOSPITALISATION 52 0.0003
738 NEUTROPENIA 46 0.0003
739 SKIN HAEMORRHAGE 5 0.0003
740 OCULAR HYPERAEMIA 16 0.0003
741 ACCIDENT 4 0.0003
742 HYPERLIPIDAEMIA 4 0.0003
743 CONSTIPATION 73 0.0003
744 EYE DISORDER 11 0.0003
745 MOBILITY DECREASED 24 0.0003
746 MYELOSUPPRESSION 12 0.0003
747 DIABETIC KETOACIDOSIS 8 0.0003
748 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 60 0.0003
749 NO ADVERSE EVENT 60 0.0003
750 ECONOMIC PROBLEM 5 0.0003
751 SKIN LESION 9 0.0003
752 WEIGHT INCREASED 73 0.0003
753 LIVER INJURY 8 0.0003
754 DRUG ADMINISTRATION ERROR 10 0.0003
755 PRURITUS GENERALISED 7 0.0003
756 CONJUNCTIVITIS 6 0.0003
757 ANKLE FRACTURE 5 0.0003
758 CONTUSION 31 0.0003
759 ILEUS 4 0.0003
760 TOXICITY TO VARIOUS AGENTS 54 0.0003
761 INJECTION SITE DISCOLOURATION 4 0.0003
762 AGGRESSION 16 0.0003
763 FOOT FRACTURE 6 0.0003
764 ANGIOEDEMA 14 0.0003
765 ABDOMINAL PAIN LOWER 8 0.0003
766 CHRONIC KIDNEY DISEASE 24 0.0003
767 LIVER DISORDER 14 0.0003
768 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
769 HAEMATEMESIS 8 0.0003
770 COMA 15 0.0003
771 FATIGUE 245 0.0003
772 OBESITY 5 0.0003
773 RASH PRURITIC 17 0.0003
774 INJURY 22 0.0003
775 PRODUCT DOSE OMISSION ISSUE 92 0.0003
776 GASTROINTESTINAL DISORDER 28 0.0003
777 LIVER FUNCTION TEST ABNORMAL 9 0.0003
778 RENAL FAILURE 41 0.0003
779 INJECTION SITE INDURATION 4 0.0003
780 BONE PAIN 18 0.0003
781 SWELLING FACE 20 0.0003
782 ECZEMA 16 0.0003
783 ALOPECIA 60 0.0003
784 SHOCK 7 0.0003
785 IMMUNE SYSTEM DISORDER 4 0.0003
786 CRYING 11 0.0003
787 CONDITION AGGRAVATED 92 0.0003
788 UPPER LIMB FRACTURE 6 0.0003
789 SYNCOPE 30 0.0003
790 BURNING SENSATION 21 0.0003
791 MEMORY IMPAIRMENT 41 0.0003
792 SOMNOLENCE 60 0.0003
793 GAIT DISTURBANCE 57 0.0003
794 CONVULSION 17 0.0003
795 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
796 CORONARY ARTERY DISEASE 9 0.0003
797 COVID-19 52 0.0003
798 PRODUCT USE ISSUE 55 0.0003
799 EMOTIONAL DISORDER 9 0.0003
800 COLITIS 11 0.0003
801 EXPOSURE DURING PREGNANCY 18 0.0003
802 INTERSTITIAL LUNG DISEASE 14 0.0003
803 DEVICE DEFECTIVE 5 0.0003
804 DRUG-INDUCED LIVER INJURY 9 0.0003
805 LOCAL SWELLING 5 0.0003
806 CEREBRAL INFARCTION 7 0.0003
807 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
808 THROMBOSIS 23 0.0003
809 CARPAL TUNNEL SYNDROME 4 0.0003
810 FEELING ABNORMAL 68 0.0003
811 IRRITABILITY 17 0.0003
812 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
813 MYALGIA 48 0.0003
814 EXTRAPYRAMIDAL DISORDER 7 0.0003
815 PAIN IN EXTREMITY 83 0.0003
816 PLATELET COUNT DECREASED 30 0.0003
817 POOR QUALITY SLEEP 6 0.0003
818 PRURITUS 107 0.0003
819 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
820 HYPOKINESIA 4 0.0003
821 RESTLESS LEGS SYNDROME 5 0.0003
822 IMPAIRED HEALING 9 0.0003
823 DRUG RESISTANCE 7 0.0003
824 RASH ERYTHEMATOUS 13 0.0003
825 DRY MOUTH 22 0.0003
826 DRUG INTERACTION 43 0.0003
827 SKIN DISORDER 9 0.0003
828 THINKING ABNORMAL 5 0.0003
829 GLOSSODYNIA 6 0.0003
830 ORAL PAIN 6 0.0003
831 HAEMORRHAGE INTRACRANIAL 4 0.0003
832 JOINT STIFFNESS 7 0.0003
833 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
834 PANCREATITIS 14 0.0003
835 BLOOD COUNT ABNORMAL 4 0.0003
836 ROAD TRAFFIC ACCIDENT 11 0.0003
837 NEUROPATHY PERIPHERAL 25 0.0003
838 DEVICE FAILURE 4 0.0003
839 ARTHRALGIA 109 0.0003
840 HERPES ZOSTER 15 0.0003
841 PULMONARY FIBROSIS 5 0.0003
842 FEAR 7 0.0003
843 INSOMNIA 69 0.0003
844 RENAL DISORDER 12 0.0003
845 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
846 BLOOD PRESSURE ABNORMAL 5 0.0003
847 UNEVALUABLE EVENT 19 0.0003
848 HEPATIC ENZYME INCREASED 17 0.0002
849 CARDIAC FAILURE CONGESTIVE 20 0.0002
850 THERAPEUTIC RESPONSE DECREASED 15 0.0002
851 DRUG INEFFECTIVE 322 0.0002
852 EYE IRRITATION 14 0.0002
853 OSTEOPOROSIS 10 0.0002
854 RIB FRACTURE 5 0.0002
855 BALANCE DISORDER 21 0.0002
856 ABASIA 6 0.0002
857 VISUAL IMPAIRMENT 30 0.0002
858 EYE SWELLING 9 0.0002
859 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
860 SLEEP DISORDER 17 0.0002
861 CYTOMEGALOVIRUS INFECTION 4 0.0002
862 DRY EYE 12 0.0002
863 MUSCULOSKELETAL STIFFNESS 21 0.0002
864 GAIT INABILITY 8 0.0002
865 TYPE 2 DIABETES MELLITUS 8 0.0002
866 HALLUCINATION, VISUAL 5 0.0002
867 ANGER 8 0.0002
868 BLOOD CHOLESTEROL INCREASED 11 0.0002
869 IMPAIRED WORK ABILITY 5 0.0002
870 SKIN ULCER 6 0.0002
871 DEVICE DISLOCATION 10 0.0002
872 DEVICE MALFUNCTION 16 0.0002
873 APPLICATION SITE PAIN 5 0.0002
874 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
875 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
876 ISCHAEMIC STROKE 4 0.0002
877 THERAPY INTERRUPTED 16 0.0002
878 EXTRA DOSE ADMINISTERED 9 0.0002
879 HEART RATE IRREGULAR 5 0.0002
880 MOOD ALTERED 6 0.0002
881 HAEMATOCHEZIA 12 0.0002
882 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
883 RHABDOMYOLYSIS 9 0.0002
884 SUICIDE ATTEMPT 13 0.0002
885 COGNITIVE DISORDER 10 0.0002
886 HALLUCINATION 16 0.0002
887 HOT FLUSH 16 0.0002
888 DEVICE ISSUE 19 0.0002
889 RASH 92 0.0002
890 LIP SWELLING 7 0.0002
891 MUSCULOSKELETAL PAIN 11 0.0002
892 PRODUCT USE IN UNAPPROVED INDICATION 52 0.0002
893 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
894 HYPOGLYCAEMIA 10 0.0002
895 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
896 DISABILITY 4 0.0002
897 JOINT SWELLING 24 0.0002
898 LACRIMATION INCREASED 6 0.0002
899 ARTHROPATHY 11 0.0002
900 SKIN IRRITATION 9 0.0002
901 CEREBRAL HAEMORRHAGE 7 0.0002
902 INJECTION SITE PRURITUS 13 0.0002
903 INJECTION SITE ERYTHEMA 24 0.0002
904 PANIC ATTACK 7 0.0002
905 SKIN EXFOLIATION 16 0.0002
906 INJECTION SITE REACTION 13 0.0002
907 INJECTION SITE PAIN 57 0.0002
908 JAUNDICE 5 0.0002
909 DRUG EFFECT DECREASED 10 0.0002
910 DIABETES MELLITUS 14 0.0002
911 OSTEONECROSIS 6 0.0002
912 OVERDOSE 39 0.0002
913 VISUAL ACUITY REDUCED 6 0.0002
914 DIVERTICULITIS 5 0.0002
915 CEREBROVASCULAR ACCIDENT 30 0.0002
916 ABORTION SPONTANEOUS 7 0.0002
917 INFLUENZA LIKE ILLNESS 14 0.0002
918 BLOOD GLUCOSE INCREASED 32 0.0002
919 BLOOD PRESSURE FLUCTUATION 4 0.0002
920 INCORRECT DOSE ADMINISTERED 38 0.0002
921 DRUG EFFECT INCOMPLETE 6 0.0002
922 EPILEPSY 5 0.0002
923 INJECTION SITE URTICARIA 4 0.0002
924 MEDICATION ERROR 9 0.0002
925 FEMUR FRACTURE 5 0.0002
926 DEVICE LEAKAGE 7 0.0002
927 CARDIAC DISORDER 15 0.0002
928 EMOTIONAL DISTRESS 19 0.0002
929 COLITIS ULCERATIVE 7 0.0002
930 HEPATITIS 4 0.0002
931 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
932 INTENTIONAL OVERDOSE 10 0.0002
933 HIP FRACTURE 5 0.0002
934 EXPOSURE VIA SKIN CONTACT 4 0.0002
935 ARTHRITIS 12 0.0002
936 ABNORMAL BEHAVIOUR 6 0.0002
937 INJECTION SITE BRUISING 12 0.0002
938 DRY SKIN 20 0.0001
939 ILL-DEFINED DISORDER 9 0.0001
940 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
941 BLINDNESS 6 0.0001
942 TREATMENT NONCOMPLIANCE 8 0.0001
943 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
944 BLOOD GLUCOSE DECREASED 7 0.0001
945 TREATMENT FAILURE 12 0.0001
946 ADVERSE DRUG REACTION 13 0.0001
947 NEOPLASM PROGRESSION 5 0.0001
948 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
949 INTENTIONAL DOSE OMISSION 4 0.0001
950 SKIN BURNING SENSATION 10 0.0001
951 SURGERY 8 0.0001
952 INJECTION SITE MASS 5 0.0001
953 DEPRESSION 30 0.0001
954 INJECTION SITE RASH 4 0.0001
955 BONE DENSITY DECREASED 4 0.0001
956 MYOCARDIAL INFARCTION 22 0.0001
957 INTENTIONAL PRODUCT MISUSE 11 0.0001
958 MULTIPLE SCLEROSIS 6 0.0001
959 DEVICE BREAKAGE 5 0.0001
960 INJECTION SITE SWELLING 9 0.0001
961 THERAPY CESSATION 6 0.0001
962 DEATH 100 0.0001
963 VAGINAL HAEMORRHAGE 5 0.0001
964 DRUG INTOLERANCE 11 0.0001
965 DRUG DOSE OMISSION 18 0.0001
966 DRUG ABUSE 9 0.0001
967 AMNESIA 7 0.0001
968 NEOPLASM MALIGNANT 7 0.0001
969 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
970 ADVERSE EVENT 9 0.0001
971 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
972 RHEUMATOID ARTHRITIS 11 0.0001
973 UNDERDOSE 7 0.0001
974 PRODUCT QUALITY ISSUE 13 0.0001
975 PRODUCT DOSE OMISSION 6 0.0001
976 PSORIASIS 12 0.0001
977 PRODUCT STORAGE ERROR 8 0.0001
978 INJECTION SITE HAEMORRHAGE 7 0.0001
979 PROSTATE CANCER 7 0.0001
980 PRODUCT SUBSTITUTION ISSUE 5 0.0001
981 DISEASE RECURRENCE 4 0.0001
982 DRUG WITHDRAWAL SYNDROME 7 0.0001
983 ACNE 6 0.0001
984 DERMATITIS ATOPIC 4 0.0001
985 DISTURBANCE IN ATTENTION 4 0.0001
986 SUICIDAL IDEATION 5 0.0001
987 DRUG DOSE OMISSION BY DEVICE 4 0.0001
988 DRUG DEPENDENCE 7 0.0000
989 BREAST CANCER 4 0.0000